Factors released by glioma-associated microglia/macrophages (GAMs) play an important role in the growth and infiltration of tumors. We have previously demonstrated that the co-chaperone stress-inducible protein 1 (STI1) secreted by microglia promotes proliferation and migration of human glioblastoma (GBM) cell lines in vitro. In the present study, in order to investigate the role of STI1 in a physiological context, we used a glioma model to evaluate STI1 expression in vivo. Here, we demonstrate that STI1 expression in both the tumor and in the infiltrating GAMs and lymphocytes significantly increased with tumor progression. Interestingly, high expression of STI1 was observed in macrophages and lymphocytes that infiltrated brain tumors, whereas STI1 expression in the circulating blood monocytes and lymphocytes remained unchanged. Our results correlate, for the first time, the expression of STI1 and glioma progression, and suggest that STI1 expression in GAMs and infiltrating lymphocytes is modulated by the brain tumor microenvironment.
Introduction
The prognosis of patients with glioblastoma (GBM), the most common primary brain tumor, remains dismal despite aggressive treatment. The high proliferative rate, intense invasiveness, and presence of the blood-brain barrier (BBB), which limits the penetration of large molecules into the central nervous system (CNS), all contribute to poor GBM response to conventional therapies (Lima et al., 2012) . Besides, the inflammatory function of the active mediators of the innate immune response, namely microglia (MG) and macrophages (MP), seems to be suppressed in gliomas and these cells may even promote tumor progression (Charles et al., 2011; Fonseca and Badie, in press ). High infiltration of MG and MP (here referred to as glioma-associated microglia/ macrophages or GAMs) into malignant gliomas (Badie and Schartner, 2000; Graeber et al., 2002) , however, suggests that targeted therapies that modulate GAMs function may be an effective immunotherapeutic approach for GBM.
The co-chaperone stress inducible protein 1 (STI1) has been described as a ligand of the cellular prion protein (PrP C ), which has several cellular functions and is highly expressed in the brain (Martins et al., 1997; Prusiner, 1998; Zanata et al., 2002; Linden et al., 2008) . The interaction between these proteins promotes neuroprotection (Chiarini et al., 2002; Zanata et al., 2002; Lopes et al., 2005) (Fonseca et al., 2012) . In fact, we were the first to demonstrate a tumor promoting role of STI1 (Erlich et al., 2007) .
Recently, we demonstrated that STI1 released by microglia promotes tumor proliferation, modulates MMP-9 activity and favors the migration of human GBM cell lines in vitro (Fonseca et al., 2012) . These observations raised the question of the role of STI1 in a physiological context. In order to investigate this, we used a glioma model to evaluate the expression of STI1 in vivo. Here, we show that STI1 expression increases with tumor progression, and is also upregulated in GAMs and infiltrating lymphocytes. In contrast, STI1 expression did not significantly change in circulating leukocytes, and even decreased in leukocytes that infiltrated tumors propagated in the subcutaneous tissue. These observations suggest that STI1 expression is modulated by brain tumor microenvironment. 
